Qing Song Health Co.,Ltd. (TPE:6931)
Taiwan · Delayed Price · Currency is TWD 40.65
-0.35 (-0.85%)
Sep 8, 2026, 12:49 PM CST
Qing Song Health Revenue
Qing Song Health had revenue of 325.75M TWD in the quarter ending June 30, 2026, with 15.36% growth. This brings the company's revenue in the last twelve months to 1.21B, up 15.23% year-over-year. In the year 2025, Qing Song Health had annual revenue of 1.12B with 14.16% growth.
Revenue (ttm)
1.21B
Revenue Growth
+15.23%
P/S Ratio
2.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.71B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12B | 139.14M | 14.16% |
| Dec 31, 2024 | 982.56M | 113.90M | 13.11% |
| Dec 31, 2023 | 868.66M | 231.98M | 36.43% |
| Dec 31, 2022 | 636.69M | 279.15M | 78.08% |
| Dec 31, 2021 | 357.54M | 117.30M | 48.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 20.75B |
| Maywufa Company | 1.64B |
| Chunghwa Chemical Synthesis & Biotech | 934.29M |
| Allied Biotech | 922.49M |
| A Plus Biotechnology | 887.93M |
| Applied BioCode | 666.54M |
| Tien Liang BioTech | 650.87M |
| Caliway Biopharmaceuticals | 29.39M |